Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      19 trials found for Lung Neoplasm, Lung Carcinoma, Lung cancer

      All(19)
      Recruiting(16)
      Not yet recruiting(3)
      Recruiting
      NCT03844464
      Safety and Efficacy of Lorbrena

      Non-small Cell Lung Cancer, Pediatric Oncology, Pediatric Lung cancer, Pediatric Lung Neoplasm, Pediatric Lung Carcinoma

      Male or Female
      0+ years
      1study location(s)
      Recruiting
      NCT06487078
      Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

      ALK+ Non-Small-Cell Lung Carcinoma

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT06321510
      A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

      Lung Cancer

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT03375242
      Safety and Efficacy of Xalkori ROS1

      Non-small Cell Lung Cancer

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT05599412
      Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

      Metastatic ALK+ Non Small Cell Lung Cancer

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT04606446
      Study of PF-07248144 in Advanced or Metastatic Solid Tumors

      Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

      Male or Female
      18+ years
      76study location(s)
      Apr 25, 2025 - Planned start date (Not yet recruiting)
      NCT06870487
      A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

      Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma, Classical Hodgkin Lymphoma, Head and Neck Squamous Cell Carcinoma, Melanoma, Non-Small Cell Lung Cancer

      Male or Female
      18+ years
      2study location(s)
      May 31, 2025 - Planned start date (Not yet recruiting)
      nct06758401
      this is a study to learn about how the combination of the study medicines sigvotatug vedotin plus pembrolizumab works in people with non-small cell lung cancer with high levels of pd-l1.

      non-small cell lung cancer, carcinoma, non-small-cell lung, carcinoma, non-small-cell lung (nsclc)

      all
      18+ years
      12study location(s)
      Dec 31, 2024 - Planned start date (Not yet recruiting)
      NCT06678555
      A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

      Carcinoma, Non-Small-Cell Lung

      Male or Female
      18 - 99 years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(19)
      Recruiting(16)
      Not yet recruiting(3)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.